Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody profiling could provide insights into disease res...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Grace, Patricia S., Dolatshahi, Sepideh, Lu, Lenette L., Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M., Ottenhoff, Tom H. M., Lauffenburger, Douglas A., Goletti, Delia, Joosten, Simone A., Alter, Galit
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287567/
https://ncbi.nlm.nih.gov/pubmed/34290702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.679973
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak